Found 4 matching trials
Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures PHASE2 This Phase 2, prospective, interventional, active extension study was desig...
Show More Location
Neurocrine Clinical Site
Learn More & Join Trial
Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) PHASE2 The objective of this study is to assess the efficacy, safety, and pharmaco...
Show More Location
UCSF Medical Center
Learn More & Join Trial
Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE PHASE2 Extension study to evaluate how safe and tolerable the drug NBI-921352 is w...
Show More Location
UCSF Medical Center
Learn More & Join Trial
A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures PHASE2 This study will evaluate the safety, pharmacokinetics, and efficacy of thre...
Show More Location
Neurocrine Clinical Site
Learn More & Join Trial